204 related articles for article (PubMed ID: 16228228)
1. Expression of gastrin and its receptor in human gastric cancer tissues.
Hur K; Kwak MK; Lee HJ; Park DJ; Lee HK; Lee HS; Kim WH; Michaeli D; Yang HK
J Cancer Res Clin Oncol; 2006 Feb; 132(2):85-91. PubMed ID: 16228228
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.
Goetze JP; Eiland S; Svendsen LB; Vainer B; Hannibal J; Rehfeld JF
Scand J Gastroenterol; 2013 Jun; 48(6):688-95. PubMed ID: 23544442
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
5. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
7. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
8. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
9. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
11. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
12. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
13. Expression of gastrin in developing gastric adenocarcinoma.
Henwood M; Clarke PA; Smith AM; Watson SA
Br J Surg; 2001 Apr; 88(4):564-8. PubMed ID: 11298626
[TBL] [Abstract][Full Text] [Related]
14. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
Rai R; Kim JJ; Tewari M; Shukla HS
J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
[TBL] [Abstract][Full Text] [Related]
16. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.
Zheng HC; Tsuneyama K; Takahashi H; Miwa S; Sugiyama T; Popivanova BK; Fujii C; Nomoto K; Mukaida N; Takano Y
J Cancer Res Clin Oncol; 2008 Apr; 134(4):481-8. PubMed ID: 17876606
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
19. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.
Suh YS; Lee HJ; Jung EJ; Kim MA; Nam KT; Goldenring JR; Yang HK; Kim WH
Ann Surg Oncol; 2012 Apr; 19(4):1240-9. PubMed ID: 22048633
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]